# Constipation in adults with cancer: assessment, prevention and treatment, including opioid-induced constipation

Source: https://onco.cc/protocols/constipation-in-adults-with-cancer/  
OnCo record `constipation-in-adults-with-cancer` (Protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Constipation is common in cancer, from pain medicines, some chemotherapy, and eating, drinking and moving less. Anyone starting a strong opioid should be prescribed a regular laxative too. Tell your team if you are constipated. Tell them straight away about severe tummy pain, vomiting, or sudden diarrhoea or leaking stool after constipation, or new leg weakness or numbness.

## Summary

Constipation in cancer has many possible causes: opioids, anticholinergics (including antidepressants and antihistamines), antacids, diuretics, neurotoxic chemotherapy (the NCI names vinca alkaloids, oxaliplatin, taxanes and thalidomide), low intake of fluid and fibre, immobility, hypercalcaemia and other metabolic disorders, a growing tumour, and spinal cord injury or compression. The NCI's assessment is a history of the bowel pattern, diet and medicines with a physical examination; a digital rectal examination may be part of it, to rule out impaction in the rectum, and MASCC says the examination should ideally include one. In immunocompromised patients the NCI says manipulation of the rectum and anus should be avoided: no rectal examinations, suppositories or enemas. If constipation persists despite preventive laxatives, obstruction and impaction are ruled out and other causes such as hypercalcaemia treated. Diarrhoea or leakage of stool in a constipated patient suggests impaction: the NCI calls leakage with nausea, vomiting, abdominal pain and dehydration virtually diagnostic.

Prevention with opioids is the best supported step: NICE CG140 says to prescribe a regular laxative for all patients starting a strong opioid, MASCC suggests routine co-prescription of a laxative or an opioid antagonist (level IV), and the NCI says a bowel regimen continues for as long as the opioid does, titrated to one unforced bowel movement every 1 to 2 days. On which laxative, the sources differ. The NCI starts a scheduled stimulant such as senna, says adding a stool softener offers no further benefit, and finds no evidence to prefer one class when constipation persists; MASCC recommends polyethylene glycol first; the Cochrane review (2015) found laxatives of similar effectiveness on limited evidence. The NCI does not advise bulk-forming agents for opioid-induced constipation. The vincristine label recommends a routine prophylactic regimen for all patients and warns that impaction can be in the upper colon with an empty rectum.

For opioid-induced constipation, a peripherally acting mu-opioid receptor antagonist is an option: NICE recommends naloxegol as an option when constipation has not adequately responded to laxatives and naldemedine as an option after laxative treatment; methylnaltrexone is given by subcutaneous injection. MASCC says these medicines should always be considered in opioid-induced constipation (level I). The NCI says they are not used if postoperative ileus or mechanical bowel obstruction is suspected. Sources differ on whether laxatives stop when one is started.

The ESMO guideline (2018) could not be read, so its graded recommendations are not reported here. The reader's own team's protocol comes first.

## Fields

- Kind: Protocol
- Last checked: 2026-11-17
- Also known as: constipation; opioid-induced constipation; OIC; laxatives with opioids; bowel regimen; faecal impaction; fecal impaction; vincristine constipation; PAMORA; peripherally acting mu-opioid receptor antagonist

## Connected records

- protocols: [Hypercalcaemia of malignancy: assessment, intravenous fluids, bisphosphonate or denosumab](https://onco.cc/protocols/hypercalcaemia-of-malignancy-management/), [Malignant bowel obstruction in advanced cancer: medicines, decompression, stents, surgery and nutrition](https://onco.cc/protocols/malignant-bowel-obstruction/), [Metastatic spinal cord compression: recognition, MSCC coordinator, MRI, dexamethasone, radiotherapy and surgery](https://onco.cc/protocols/metastatic-spinal-cord-compression-emergency/), [Opioid switching and dose conversion in adults with cancer pain](https://onco.cc/protocols/opioid-switching-and-conversion/), [Strong opioids for cancer pain: starting, titrating, rescue doses and preventing constipation](https://onco.cc/protocols/strong-opioids-for-cancer-pain/)
- drugs: [Methylnaltrexone](https://onco.cc/drugs/methylnaltrexone/), [Morphine](https://onco.cc/drugs/morphine/), [Ondansetron](https://onco.cc/drugs/ondansetron/), [Oxycodone](https://onco.cc/drugs/oxycodone/), [Vincristine](https://onco.cc/drugs/vincristine/)

---
JSON: https://onco.cc/api/v1/entities/constipation-in-adults-with-cancer.json